(BRKR) Bruker - Ratings and Ratios

Bruker Corporation (NASDAQ:BRKR) is a leading developer, manufacturer, and distributor of scientific instruments and analytical solutions. Operating globally, the company serves markets in the United States, Europe, Asia Pacific, and other regions. Bruker is organized into four main segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

The company offers a wide range of life science tools, including single and multiple modality systems, life science mass spectrometry solutions, and advanced molecular diagnostics. Key products include the MALDI Biotyper platform for rapid pathogen identification, DNA test strips, and fluorescence-based PCR technology. Bruker also provides genotype and fluorotype molecular diagnostics kits, as well as SARS-CoV-2 testing solutions for COVID-19 diagnosis, including Fluorotyper-SARS-CoV-2 plus kits.

In the analytical space, Bruker supplies portable analytical and bioanalytical detection systems, X-ray instruments, and advanced tools for electron microscopes. The company is known for its handheld, portable, and mobile X-ray fluorescence spectrometry instruments, atomic force microscopy (AFM) systems, and non-contact nanometer resolution solution topography solutions. Additionally, Bruker offers automated X-ray metrology, AFM defect-detection, and photomask repair and cleaning equipment.

Bruker also delivers advanced optical fluorescence microscopy instruments and solutions tailored for multi-omics research, translational medicine, drug discovery, and biomarker development. The company’s superconducting materials division produces metallic low-temperature superconductors, devices, and complex tools based on these materials. It also manufactures non-superconducting high-technology tools, including synchrotron and beamline instrumentation.

Founded in 1991, Bruker Corporation is headquartered in Billerica, Massachusetts. The company has established itself as a key player in the life sciences tools and services sector, with a market capitalization of approximately $7.75 billion USD. As of recent data, Bruker trades with a P/E ratio of 67.30 and a forward P/E of 20.49, reflecting its growth prospects and market position. The stock is listed on the NASDAQ exchange under the ticker symbol BRKR.